A61L 2300/60
Biologically active materials used in bandages, wound dressings, absorbent pads or medical
Official title: characterised by a special physical form
A61L2300/60 (Biologically active materials used in bandages, wound dressings, absorbent pads or medical) appears on 3,845 US grants and 6,150 published applications in this corpus.
Search patents in A61L- Granted patents
- 3,845
- Published applications
- 6,150
- Assignees
- 2,072
- Inventors
- 8,997
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 0 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 5 | 0 |
| 1986 | 6 | 0 |
| 1987 | 4 | 0 |
| 1988 | 7 | 0 |
| 1989 | 9 | 0 |
| 1990 | 12 | 0 |
| 1991 | 10 | 0 |
| 1992 | 12 | 0 |
| 1993 | 19 | 0 |
| 1994 | 45 | 0 |
| 1995 | 33 | 0 |
| 1996 | 32 | 0 |
| 1997 | 55 | 0 |
| 1998 | 65 | 0 |
| 1999 | 57 | 0 |
| 2000 | 47 | 0 |
| 2001 | 64 | 27 |
| 2002 | 68 | 145 |
| 2003 | 83 | 213 |
| 2004 | 68 | 239 |
| 2005 | 56 | 261 |
| 2006 | 68 | 279 |
| 2007 | 67 | 314 |
| 2008 | 63 | 288 |
| 2009 | 61 | 274 |
| 2010 | 126 | 328 |
| 2011 | 159 | 265 |
| 2012 | 189 | 257 |
| 2013 | 184 | 239 |
| 2014 | 243 | 262 |
| 2015 | 223 | 370 |
| 2016 | 229 | 414 |
| 2017 | 233 | 249 |
| 2018 | 195 | 257 |
| 2019 | 185 | 265 |
| 2020 | 202 | 205 |
| 2021 | 148 | 200 |
| 2022 | 109 | 211 |
| 2023 | 115 | 167 |
| 2024 | 117 | 193 |
| 2025 | 99 | 158 |
| 2026 | 58 | 70 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Color-changing antibacterial nanofiber29 Sep 2026US 12,746,214 B2University of Manitoba
- Method for manufacturing hemostatic medical material15 Sep 2026US 12,734,267 B2
- Gum olibanum nanofibers for drug release and wound healing applications8 Sep 2026US 12,728,180 B1King Saud University
- Active agent-eluting hemostatic agents for prevention of surgical site infection1 Sep 2026US 12,721,928 B1Florida Southern College
- Cationic nanodrug, preparation method therefor, and drug-loaded implantable medical device1 Sep 2026US 12,721,934 B2Shanghai Microport Medical (Group) Co., Ltd.
- Segmented calcium phosphate bone scaffolds with sacrificial zones for mechano-transductive bone regeneration and methods of making and using the same1 Oct 2026US 2026/0294629 A1Board of Regents, The University of Texas System
- Solid forms for tissue repair1 Oct 2026US 2026/0294634 A1Cartiheal (2009) Ltd.
- Antimicrobial compositions and sutures coated therewith1 Oct 2026US 2026/0295111 A1Covidien LP
- Fatty acid-grafted hyaluronic acid, dermal filler formulations comprising same, process for preparation and use thereof1 Oct 2026US 2026/0295116 A1MERZ PHARMA GmbH & CO. KGaA
- Target for combatting the foreign body response to implantable biomaterials1 Oct 2026US 2026/0295119 A1The Regents of the University of Colorado, a body corporate
Most cited
By later US patents
- Drug releasing anastomosis devices and methods for treating anastomotic sites1,779US 7,108,701 B2Ethicon, Inc. · 2006
- Methods and apparatus for a coated anchoring device and/or suture1,702US 6,689,153 B1Orthopaedic Biosystems Ltd., Inc. · 2004
- Surgical implant and method for controlled release of chemotherapeutic agents1,679US 5,290,271 A1994
- Drug releasing biodegradable fiber implant1,662US 6,596,296 B1Board of Regents, The University of Texas System · 2003
- Microporous vascular graft1,647US 5,024,671 ABaxter International Inc. · 1991